CD79A and pancreatic serous cystadenoma: Recently, IgA-class antibodies against glycoprotein 2 (anti-GP2 IgA), which were formerly linked to severe types of Crohn’s disease (144), were detected in sera of patients with PSC at a prevalence of 46.7–71.5%.